Pet Healthcare Global Market Report 2026

Pet healthcare involves a comprehensive approach that combines preventive and therapeutic measures to maintain the well-being of pet animals and keep them free from diseases. This approach is instrumental in promoting a healthy pet lifestyle. It encompasses a multifaceted strategy, which includes regular assessments by a veterinarian to evaluate the pet's overall health and assess the potential for illnesses or other health issues.

The primary types of pet healthcare encompass therapeutics and diagnostics. Therapeutics include products such as vaccines, anti-parasitic medications, and feed additives, designed to treat already-infected pets. These therapeutic products cater to various types of animals, including canines, felines, equines, avian pets, and others. They are made available through diverse distribution channels, including retail outlets, e-commerce platforms, and hospital pharmacies, ensuring accessibility for pet owners seeking healthcare solutions for their animals.

Tariffs have influenced the pet healthcare market by increasing costs of imported vaccines, anti-infective drugs, imaging equipment, and specialized diagnostics. Segments such as therapeutics and diagnostics are most affected, particularly in North America, Europe, and Asia-Pacific where imports are significant. While tariffs may raise operational costs, they also encourage local production, innovation in domestic pet healthcare products, and the development of cost-effective diagnostic solutions.

The pet healthcare market research report is one of a series of new reports from The Business Research Company that provides pet healthcare market statistics, including pet healthcare industry global market size, regional shares, competitors with a pet healthcare market share, detailed pet healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the pet healthcare industry. This pet healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pet healthcare market size has grown strongly in recent years. It will grow from $269.01 billion in 2025 to $293.14 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to rising pet ownership, increasing disposable income, awareness about zoonotic diseases, expansion of veterinary infrastructure, growth of companion animal segment.

The pet healthcare market size is expected to see strong growth in the next few years. It will grow to $421.68 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to integration of telehealth and digital veterinary platforms, development of advanced pet therapeutics, growth in genetic and microbiome testing, rising demand for personalized pet nutrition, increased adoption of preventive care programs. Major trends in the forecast period include growing awareness of preventive pet healthcare, increase in routine health check-ups for pets, expansion of nutraceuticals and functional foods for pets, adoption of telemedicine and remote consultations, rising focus on multi-species pet health management.

The increasing pet ownership is expected to drive the growth of the pet healthcare market in the coming years. Pet ownership refers to being the primary individual or household responsible for the care, well-being, and management of a domesticated animal. It entails a long-term, legal, and ethical responsibility. The rise in pet ownership is attributed to growing awareness of the emotional and health benefits of having pets, as people seek companionship, stress relief, and enhanced well-being through pet care. Pet healthcare supports this growth by ensuring pets' well-being and longevity through preventive care and by offering health education that enables new pet owners to make informed decisions regarding their animals' care. For example, in March 2025, according to the American Pet Products Association, a US-based non-profit organization, ninety-four (94) million U.S. households owned at least one pet, compared to eighty-two (82) million in 2023. Hence, the rising pet ownership is boosting the pet healthcare market.

Leading players in the pet healthcare market are introducing innovative digital platforms to maintain their market position. These innovative digital platforms include online tools and mobile applications that offer pet health monitoring, telemedicine, appointment scheduling, and personalized care recommendations. For instance, in October 2023, Cargill Incorporated, a US-based company, launched a pet health-focused digital platform called Zoonivet, designed to deliver convenient and accessible veterinary care through e-consultations. The platform aims to streamline pet healthcare by connecting pet owners with qualified veterinarians remotely via video for their pets' primary healthcare needs.

In December 2023, Zenex Animal Health, an animal health company based in India, successfully acquired Ayurveda for an undisclosed sum. This strategic acquisition is anticipated to enhance Zenex's product portfolio by incorporating herbal offerings, thereby improving the overall quality of its animal health products. Ayurvet, an India-based pet healthcare company, is known for its specialization in providing natural and safe Ayurvedic and herbal medicines tailored for pets. The integration of Ayurveda into Zenex Animal Health's operations represents a strategic move to further diversify and enhance the company's capabilities in the animal health sector.

Major companies operating in the pet healthcare market are Nestle SA, Merck & Co Inc., Mars Inc., Indian Immunologicals Limited, Boehringer Ingelheim International GmbH, Colgate-Palmolive Company, Chewy Inc., Zoetis Inc., Petco Animal Supplies Inc., VCA Animal Hospitals Inc., Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Royal Canin, Ceva Sante Animale, Phibro Animal Health Corporation, Trupanion, Vetoquinol S.A., Norbrook Laboratories Ltd., Heska Corporation, Biogenesis Bago SA, Pumpkin Insurance Services Inc., PetFirst Healthcare LLC, Embark Veterinary Inc., Agrolabo SpA, Bayer Animal Health GmbH, Bioniche Animal Health Canada Inc., Novartis Animal Health US Inc.

North America was the largest region in the pet healthcare market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global pet healthcare market report during the forecast period. The regions covered in the pet healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pet healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The pet healthcare market consists of sales of pet healthcare diagnostic tools, medicines and preventive care products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pet Healthcare Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pet healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pet healthcare ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pet healthcare market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Therapeutics; Diagnostics
• 2) By Animal Type: Canine; Feline; Equine; Avian; Other Animals
• 3) By Distribution Channel: Retail; E-Commerce; Hospital Pharmacies
• Subsegments:
• 1) By Therapeutics: Vaccines; Anti-Infective Drugs; Anti-Inflammatory Drugs; Pain Management Medications; Parasiticides; Nutraceuticals
• 2) By Diagnostics: Laboratory Diagnostics; Imaging Diagnostics; Point-Of-Care Testing; Genetic Testing; Microbiome Testing
• Companies Mentioned: Nestle SA; Merck & Co Inc.; Mars Inc.; Indian Immunologicals Limited; Boehringer Ingelheim International GmbH; Colgate-Palmolive Company; Chewy Inc.; Zoetis Inc.; Petco Animal Supplies Inc.; VCA Animal Hospitals Inc.; Elanco Animal Health Incorporated; IDEXX Laboratories Inc.; Royal Canin; Ceva Sante Animale; Phibro Animal Health Corporation; Trupanion; Vetoquinol S.A.; Norbrook Laboratories Ltd.; Heska Corporation; Biogenesis Bago SA; Pumpkin Insurance Services Inc.; PetFirst Healthcare LLC; Embark Veterinary Inc.; Agrolabo SpA; Bayer Animal Health GmbH; Bioniche Animal Health Canada Inc.; Novartis Animal Health US Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.